Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and pathological characteristics of familial melanoma with germline
TERT
promoter variants
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-08-01
DOI
10.1111/pcmr.13060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
- (2021) Carl M. Thielmann et al. EUROPEAN JOURNAL OF CANCER
- Germline mutations predisposing to melanoma
- (2020) Atrin Toussi et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
- (2020) Y. Nakamura et al. ANNALS OF ONCOLOGY
- Clinical, environmental and histological distribution of BRAF , NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients
- (2020) E. Manrique‐Silva et al. BRITISH JOURNAL OF DERMATOLOGY
- FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma
- (2020) Elizabeth A. Holland et al. Familial Cancer
- Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
- (2020) Felicity Newell et al. Nature Communications
- A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing
- (2020) Sounak Gupta et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
- (2019) Felicity Newell et al. Nature Communications
- Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations and DNA methylation profiling
- (2018) Klaus Griewank et al. CLINICAL CANCER RESEARCH
- Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast
- (2018) Julia Y. S. Tsang et al. Scientific Reports
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
- (2017) Ioana Cosgarea et al. Oncotarget
- Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma
- (2017) Brittani Seynnaeve et al. Scientific Reports
- Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system
- (2016) Johannes van de Nes et al. JOURNAL OF NEURO-ONCOLOGY
- Familial skin cancer syndromes
- (2016) Katherine J. Ransohoff et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Germline TERT promoter mutations are rare in familial melanoma
- (2015) Mark Harland et al. Familial Cancer
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Evaluation of Copy Number Variation Detection Tools from Whole-Exome Sequencing Data
- (2014) Renjie Tan et al. HUMAN MUTATION
- TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
- (2014) Helena Pópulo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- High risk of tobacco-related cancers inCDKN2Amutation-positive melanoma families
- (2014) Hildur Helgadottir et al. JOURNAL OF MEDICAL GENETICS
- Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling
- (2014) Miriam Potrony et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
- (2014) Klaus G. Griewank et al. JNCI-Journal of the National Cancer Institute
- Genome-wide analysis of noncoding regulatory mutations in cancer
- (2014) Nils Weinhold et al. NATURE GENETICS
- Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
- (2014) Barbara Heidenreich et al. Nature Communications
- The RASopathies
- (2013) Katherine A. Rauen Annual Review of Genomics and Human Genetics
- TERT promoter mutations in cancer development
- (2013) Barbara Heidenreich et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- CONTRA: copy number analysis for targeted resequencing
- (2012) Jason Li et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search